Pharmaceutical Industry

Page 85 of 100

Turing Pharmaceutical CEO Martin Shkreli Arrested For Securities Fraud
Health

How Pharmacies Are Dealing with Daraprim After Martin Shkreli’s Arrest

By
December 18, 2015
BRITAIN-PHARMACEUTICAL-GSK
Health

Europe’s Pharma Sector Is Finishing 2015 With a Deal Flurry

By
December 18, 2015
BRITAIN-PHARMA-BUSINESS-ASTRAZENECA
Finance

The Year’s Best VC Deal Was for a Company You’ve Never Heard Of

By
December 17, 2015
BRITAIN-PHARMA-BUSINESS-ASTRAZENECA
Health

AstraZeneca Wants a Stake in This Biotech Firm for a Cancer Cure

By
December 17, 2015
Views Of A CVS Caremark Corp. Store Ahead Of Earns
Retail

CVS Slams Walgreens-Valeant Distribution Deal

By
December 16, 2015
MSMB Capital Management CIO Martin Shkreli
Leadership

Yet Another Reason to Hate Martin Shkreli

By
December 16, 2015
468673318
Health

Here’s How Your Health Care Is Going to Change in 2016

By
December 16, 2015
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
Finance

Congressman Calls Out Valeant’s ‘Lack of Transparency’

By
December 16, 2015
J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., waits for the start of their annual general meeting in Laval, Quebec
Retail

Walgreens Comes to Valeant’s Help

By
December 15, 2015
Cindy Whitehead, chief executive officer of Sprout Pharmaceuticals Inc., speaks during a Bloomberg Television interview in New York, U.S., on Wednesday, Aug. 19, 2015. Whitehead discussed Addyi, the company's pill for low libido in women that won approval from the U.S. Food and Drug Administration yesterday. Photographer: Chris Goodney/Bloomberg *** Local Caption *** Cindy Whitehead
MPW

CEO Behind ‘Female Viagra’ Leaves Company After Valeant Purchase

By
December 10, 2015
This Is What Happens When Cheap Drugs Get Wildly Expensive
Health

This Is What Happens When Cheap Drugs Get Wildly Expensive

By
December 9, 2015
MSMB Capital Management CIO Martin Shkreli
Health

Infamous Pharma CEO Martin Shkreli Paid $2 Million for a Wu-Tang Album

By
December 9, 2015
Yuan Direction and Drug Price Hearing–5 Things to Know Today
Leadership

Yuan Direction and Drug Price Hearing–5 Things to Know Today

By Laura Lorenzetti and Geoffrey Smith
December 9, 2015
468673318
Health

U.S. Health Care Spending Accelerates After Historic Lows

By
December 3, 2015
Inside The Pfizer Inc. Kendall Square Research Facility Ahead Of Earnings Figures
Health

Troubles Ahead for the Pharmaceutical Industry

By
December 3, 2015

Most Popular